The chromatin remodeler ADNP regulates neurodevelopmental disorder risk genes and neocortical neurogenesis

S Samuel Clémot-Dupont (Regenerative Medicine Program, Ottawa Hospital Research Institute) J José Alex Lourenço Fernandes (Regenerative Medicine Program, Ottawa Hospital Research Institute) S Sarah Larrigan (Regenerative Medicine Program, Ottawa Hospital Research Institute) X Xiaoqi Sun (Department of Chemistry, College of Science) S Suma Medisetti (Regenerative Medicine Program, Ottawa Hospital Research Institute) R Rory Stanley (Regenerative Medicine Program, Ottawa Hospital Research Institute) Z Ziyad El Hankouri (Regenerative Medicine Program, Ottawa Hospital Research Institute) S Shrilaxmi V. Joshi (Regenerative Medicine Program, Ottawa Hospital Research Institute) D David J. Picketts (Regenerative Medicine Program, Ottawa Hospital Research Institute) K Karthik Shekhar (Department of Chemical and Biomolecular Engineering, University of California) P Pierre Mattar (Regenerative Medicine Program, Ottawa Hospital Research Institute)

Abstract

Although chromatin remodelers are among the most important risk genes associated with neurodevelopmental disorders (NDDs), the roles of these complexes during brain development are in many cases unclear. Here, we focused on the recently discovered ChAHP chromatin remodeling complex. The zinc finger and homeodomain transcription factor ADNP is a core subunit of this complex, and de novo ADNP mutations lead to intellectual disability and autism spectrum disorder. However, germline Adnp knockout mice were previously shown to exhibit early embryonic lethality, obscuring subsequent roles for the ChAHP complex in neurogenesis. To circumvent this early developmental arrest, we generated a conditional Adnp mutant allele. Using single-cell transcriptomics, cut&run-seq, and histological approaches, we show that during neocortical development, Adnp orchestrates the production of late-born, upper-layer neurons through a two-step process. First, Adnp is required to sustain progenitor proliferation specifically during the developmental window for upper-layer cortical neurogenesis. Accordingly, we found that Adnp recruits the ChAHP subunit Chd4 to genes associated with progenitor proliferation. Second, in postmitotic differentiated neurons, we define a network of risk genes linked to NDDs that are regulated by Adnp and Chd4. Taken together, these data demonstrate that ChAHP is critical for driving the expansion of upper-layer cortical neurons and for regulating neuronal gene expression programs, suggesting that these processes may potentially contribute to NDD etiology.

Article Details

Volume / Issue Vol. 122, Issue 3
Published January 21, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (11)

S

Samuel Clémot-Dupont

Regenerative Medicine Program, Ottawa Hospital Research Institute

J

José Alex Lourenço Fernandes

Regenerative Medicine Program, Ottawa Hospital Research Institute

S

Sarah Larrigan

Regenerative Medicine Program, Ottawa Hospital Research Institute

X

Xiaoqi Sun

Department of Chemistry, College of Science

S

Suma Medisetti

Regenerative Medicine Program, Ottawa Hospital Research Institute

R

Rory Stanley

Regenerative Medicine Program, Ottawa Hospital Research Institute

Z

Ziyad El Hankouri

Regenerative Medicine Program, Ottawa Hospital Research Institute

S

Shrilaxmi V. Joshi

Regenerative Medicine Program, Ottawa Hospital Research Institute

D

David J. Picketts

Regenerative Medicine Program, Ottawa Hospital Research Institute

K

Karthik Shekhar

Department of Chemical and Biomolecular Engineering, University of California

P

Pierre Mattar

Regenerative Medicine Program, Ottawa Hospital Research Institute